Test description
Mutations in the FLT3 and NPM1 genes are seen in acute myeloid leukaemia (particularly in cases with a normal cytogenetic karyotype) and are of prognostic significance.
Test information
Test name
Nucleophosmin & FLT3
Clinical indication
For diagnosis, prognosis, and classification in acute myeloid leukaemia
Gene(s)
NPM1, FLT3
Method
Real-time PCR analysis; Conventional PCR and capillary electrophoresis
Turn around time
2 weeks
Medicare eligibility
Price
If not MBS eligible please contact 1800 822 999 for details
Test request form
Standard pathology request form
Sample type
6mL Blood EDTA tube or 1 mL bone marrow EDTA tube
Collection type
Blood or bone marrow
Special instructions
Test is performed on either peripheral blood or bone marrow aspirate. Peripheral blood can be collected by a collector, bone marrow aspirate (doctor collect only) must be placed into EDTA.